Oncology Collaboration and Licensing Agreements Analysis Report 2024: SEC-Linked Oncology Contract Documents Reveal In-Depth Deal Structures and Payment Clauses
September 30, 2024 05:03 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offeringThe report provides access to deal...
Prostate Cancer in the United States: Key Insights into Treatment Awareness & Satisfaction - Make Informed, Strategic Decisions, Identify Opportunities, and Understand Potential Challenges
September 26, 2024 04:15 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing
September 25, 2024 09:07 ET
|
Koelis
Koelis is pleased to announce the introduction of our new 3D ultrasound probe that maximizes auto reprocessing compatibility.
Comprehensive Urology Studies ED Injections with Shockwave Therapy for Penile Girth Enhancement
September 23, 2024 15:34 ET
|
Comprehensive Urology
Comprehensive Urology of Los Angeles studies STUD Protocol for male enhancement in survivors of prostate cancer during Prostate Cancer Awareness Month.
La « Distinguished Gentleman's Drive » fête sa quatrième année dimanche le 29 septembre 2024
September 23, 2024 07:30 ET
|
Movember Canada
TORONTO, 23 sept. 2024 (GLOBE NEWSWIRE) -- Le Distinguished Gentleman's Drive (DGD) est une célébration du style classique. C'est un événement de levée de fonds sur la route qui réunit des...
The Distinguished Gentleman’s Drive Celebrates Its Fourth Year on Sunday, September 29, 2024
September 23, 2024 07:30 ET
|
Movember Canada
TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Distinguished Gentleman’s Drive (DGD) is a celebration of classic style. It’s an on-road fundraising event that unites classic cars – aged 40 years...
Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
September 20, 2024 09:07 ET
|
Koelis
Koelis finalizes partnership with Deep Health for AI-powered prostate MRI interpretation and guidance in fusion biopsy for prostate cancer.
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
September 15, 2024 08:45 ET
|
Lantheus Holdings, Inc.
Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0% for the ARPI switch arm, including 9.3%...
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
September 15, 2024 03:00 ET
|
MacroGenics, Inc.
Encouraging antitumor activity demonstrated with vobra duo as measured by 6-month landmark rPFS rate and ORRPatients remained on vobra duo through a median of 6 doses (ranging up to 12), representing...
Harvey Homan to Highlight MetasTx’s Game-Changing Approach to Cancer Treatment at PA Life Science Futures
September 12, 2024 06:58 ET
|
MetasTx LLC
MetasTx aims to revolutionize cancer treatment by targeting p21-activated kinase (PAK-1), a critical driver of metastasis in solid tumors.